Live feed
Filing
SC 13D/A
SC 13D/A0000947871-20-000143·Eledon Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Novus Therapeutics, Inc.
Security class unavailable · CUSIP: 67011N105
Event date: 2020-02-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-20-000143
- Form type
- SC 13D/A
- Filer
- Eledon Pharmaceuticals, Inc.
- CIK
- CIK 1404281
- Filed
- Feb 25, 2020
- Reporting period
- Feb 20, 2020
- Description
- Schedule 13D beneficial ownership